Richard S. Kollender

Richard Kollender is an accomplished financial executive with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as the Chief Financial Officer and Chief Business Officer at Reaction Biology since April 2022, Richard also holds the position of Chairman at Restorative Therapies and has been a Board Member at Rapid Micro Biosystems since July 2009, where Richard has previously functioned as CBO/CFO. As Managing Partner at Quaker Partners, Richard has overseen a healthcare investment firm managing over $700 million. Richard's past roles include President and CFO of Strongbridge Biopharma plc and various leadership positions at GSK and S.R. One Ltd. Richard's educational background includes an MBA from The University of Chicago Booth School of Business and a BA from Franklin & Marshall College.